Anti-tumoral activity of Acetogenins derived from Soursop Fruit (Annona
muricata L.) in High Grade Serous Ovarian Cancer
Roger Neuberger,1 Efigenia Montalvo-González, 1,3 Paola Amero,1 Cristian Rodriguez-Aguayo,1,2 Gabriel Lopez-Berestein1,2
1Department

of Experimental Therapeutics and 2Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center,
Houston, Texas, 77030.
3Integral Laboratory of Food Research, Mexican National Technological Institute/ Campus Technological Institute of Tepic, Avenue Tecnologico 2595, 63175 Tepic,
Nayarit, Mexico.

Background

In 2021, the American Cancer Society estimated that
approximately 21,410 women will receive a new
diagnosis of ovarian cancer and about 13,770 women
will die from ovarian cancer in the United States. This
type of cancer is treated with cyto-reductive surgery,
radiotherapy and hormone therapy, but unfortunately,
these treatments are often insufficient, and patients
frequently relapse and succumb to the disease (Yajid et
al., 2018).
The Annona muricata plant contains specific
compounds denominated acetogenins (ACGs), which
are characterized by C35 or C37 unbranched fatty acid
with a γ-lactone at the end of the skeleton (Kim et al.,
1998). A single report demonstrated ACGs might
increase or decrease the expression of Notch receptors
(Li et al., 2017) in cancer cells. The Notch signaling
pathway controls a variety of cellular processes, such
as cell proliferation, differentiation, apoptosis, and
survival. Additionally, abnormities of Notch signaling
is associated with oncogenesis, which usually
manifests as abnormality ligands, receptors, and
downstream proteins (Hu et al., 2012).

Results

Figure 2. ACGs were found to inhibit proliferation of OVCAR5 (top) and OVCAR8 (bottom) cells in vitro.

In this study, we isolated and characterized ACGs,
modulators of the Notch pathway, and demonstrate
their antitumoral activity in ovarian cancer.

General Aims

Figure 3. It was observed that ACGs significantly decreased colony formation in both OVCAR5 (p=0.004)
and OVCAR8 (p=0.0042) cells compared to the negative controls.

Our primary goals were to characterize the Notch
signaling-pathway and explain the anti-tumoral
activity of ACGs in ovarian cancer. We
hypothesized there would be a down-regulation of
the Notch receptors as well as reduced metastatic
capability following treatment with ACGs.
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Figure 4. Western blot analysis showed a reduction of Notch1 and p-Erk1/2, in line with the decreased
colony formation observed.
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Figure 1. Soursop fruit (left) and structure of
Annonacin-10-ona (right).

In this study, we demonstrated that using ACGs to
target Notch signaling has both antitumoral and antimetastatic effect in high grade ovarian cancer. The
many biological and clinical aspects of ovarian
tumorigenesis indicate that an aberrant activation of
Notch signaling pathway is involved in tumor
initiation, progression, metastasis, resistance to
chemotherapy, and angiogenesis. Based on previous
reports, we hypothesized ACGs would down-regulate
the Notch signaling-pathway, and thus inhibit these
behaviors.
In the current study, we demonstrated for the first time
that treatment with ACGs decreased Notch1
expression in a dose-dependent manner in OVCAR5,
and higher concentrations of ACGs similarly
decreased the expression of the same receptors in
OVCAR8. It was additionally found that treatment
with ACGs decreased proliferation in these same cell
lines.
Cancer metastasis is dependent on the cells’ migratory
ability and proliferative capabilities. And it was found
by wound-healing assay demonstrated that ACGs
inhibit the migratory activity of ovarian cancer cells in
vitro. Together with the noted anti-proliferative effects
of ACGs, this suggests they may be effective at
preventing metastasis. These effects may be explained
by the reductions observed in p-Erk1/2 and Notch1
following treatment with ACGs, both involved in
pathways that modulate cancer cell migration and
proliferation.
The results presented here indicate that ACGs isolated
from Annona muricata act as anti-metastatic agents
that can attenuate the proliferation of HGSOC, and
they may provide a novel therapeutic approach against
HGSOC. With few treatment options available, ACGs
have the potential to greatly improve patient outcomes,
although further studies will be necessary to confirm
their effects in vivo.

Translational significance

ACGs isolated from plants of the genus Annonaceae
have been shown to have antitumor effects in cancer
cell lines. However, the molecular signaling pathways
underlying this effect are not fully understood. Our
findings suggest a regulatory effect of ACGs derived
from soursop fruit pulp on Notch signaling pathway in
HGSOC, suggesting they may pose a potential
therapeutic approach against ovarian cancer.

Methods

Cells were plated onto 24-well plates (300 cells/well).
After, they were treated with ACGs (0, 15, and 25
nM). They were incubated in 5% CO2 and 95% air at
37 ºC for 10 days to form colonies. At the end of the
incubation, the colonies were stained with crystal
violet and counted.
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